- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jiangsu Recbio Technology Co Ltd (2179)
Track today's live Jiangsu Recbio Technology (2179) share price, performance and key data on this page with our current Hong Kong:2179 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Jiangsu Recbio Technology share price on the Hong Kong exchange. Use the dropdown to switch exchange for the 2179 share price, head to our technical summary section, which provides analysis on Jiangsu Recbio Technology share price buy/sell indicators using real-time data (or discuss the Jiangsu Recbio Technology (2179) stock price today with other investors in the Jiangsu Recbio Technology HK share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current HK:2179 share price (ISIN: CNE1000057K9) to enhance your trading decisions with our free investment tools and resources.
What Is the Jiangsu Recbio Technology Co Ltd Share Price Today?
The Jiangsu Recbio Technology share price today is 4.90.
What Is the Stock Symbol for Jiangsu Recbio Technology Co Ltd
The stock symbol (or 'ticker') for Jiangsu Recbio Technology Co Ltd is "2179."
What Stock Exchange Does Jiangsu Recbio Technology Co Ltd Trade On?
Jiangsu Recbio Technology Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Jiangsu Recbio Technology Co Ltd a Good Stock to Buy?
Determining whether Jiangsu Recbio Technology (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current HK:2179 share price (ISIN: CNE1000057K9) to enhance your trading decisions with our free investment tools and resources.
What Is the Jiangsu Recbio Technology Co Ltd Share Price Today?
The Jiangsu Recbio Technology share price today is 4.90.
What Is the Stock Symbol for Jiangsu Recbio Technology Co Ltd
The stock symbol (or 'ticker') for Jiangsu Recbio Technology Co Ltd is "2179."
What Stock Exchange Does Jiangsu Recbio Technology Co Ltd Trade On?
Jiangsu Recbio Technology Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Jiangsu Recbio Technology Co Ltd a Good Stock to Buy?
Determining whether Jiangsu Recbio Technology (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Hong Kong
Currency in HKD
4.90
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.90
4.90
52 wk Range
3.40
7.80
2179 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.904.90
52 wk Range
3.407.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2179 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Earnings
Latest Release
19/08/2026
EPS / Forecast
-0.34 / --
Revenue / Forecast
7.5M / --
Compare 2179 to Peers and Sector
Metrics to compare | 2179 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2179PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.4x | −14.2x | −0.4x | |
PEG Ratio | −0.13 | 0.02 | 0.00 | |
Price/Book | 5.2x | 3.5x | 2.6x | |
Price / LTM Sales | 5,255.6x | 11.5x | 3.0x | |
Upside (Analyst Target) | - | 56.8% | 51.3% | |
Fair Value Upside | Unlock | 7.2% | 7.8% | Unlock |
Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic of China. The company develops vaccines for the treatment of cervical cancers, and anal and genital warts, including REC603, a recombinant human papillomavirus (HPV) 9-valent vaccine that is in phase III clinical trial; REC601, a recombinant HPV bivalent vaccines targeting HPV type 16/18 that is in phase I clinical trial; REC602, recombinant HPV bivalent vaccines targeting HPV type 6/11, which is in phase I clinical trials; REC604a, a novel adjuvanted recombinant HPV quadrivalent vaccine; and REC604c, a recombinant HPV 9-valent vaccine. It also develops REC610, a recombinant shingles vaccine that is in Phase l clinical trial; REC625, a bivalent recombinant respiratory syncytial virus vaccine and REC627, a recombinant metapneumovirus vaccine for the treatment of respiratory diseases caused by respiratory syncytial virus; REC609, a recombinant human cytomegalovirus vaccine for the treatment of human cytomegalovirus disease; and ReCOV, a recombinant bicomponent COVID-19 vaccine candidate that completed phase III clinical trial. In addition, the company develops REC629, a recombinant Hepatitis B virus vaccine and REC630, a therapeutic recombinant Hepatitis B virus vaccine for the treatment of disease caused by hepatitis B virus infection; REC608, a recombinant herpes simplex virus vaccine; and REC617, a recombinant influenza vaccine. Jiangsu Recbio Technology Co., Ltd. was founded in 2011 and is headquartered in Taizhou, the People’s Republic of China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Jiangsu Recbio Technology (Hong Kong: 2179) Share Price Today?
The Jiangsu Recbio Technology stock price today is 4.90 HKD.
What Stock Exchange Does Jiangsu Recbio Technology (2179) Trade On?
Jiangsu Recbio Technology is listed and trades on the Hong Kong Stock Exchange.
What Is the Ticker (Stock Symbol) for Jiangsu Recbio Technology?
The stock symbol (also called a 'ticker') for Jiangsu Recbio Technology is "2179."
What Is the Current Jiangsu Recbio Technology Market Capitalisation?
As of today, Jiangsu Recbio Technology (Hong Kong: 2179) market cap is 3.02B HKD.
What Is Jiangsu Recbio Technology's (2179) Earnings Per Share (TTM)?
The Jiangsu Recbio Technology EPS is currently -0.80 (Trailing Twelve Months).
Is 2179 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Jiangsu Recbio Technology moving averages and other technical indicators, the daily buy/sell signal for 2179 stock is Strong Sell.
How Many Times Has Jiangsu Recbio Technology Stock Split?
Jiangsu Recbio Technology has split 0 times. (See the 2179 stock split history page for full effective split date and price information.)
How Many Employees Does Jiangsu Recbio Technology Have?
Jiangsu Recbio Technology has 466 employees, based on their latest Companies House report.
What is the current trading status of Jiangsu Recbio Technology (Hong Kong: 2179)?
As of 10/09/2026, Jiangsu Recbio Technology (2179) is trading at a share price of 4.90 HKD, with a previous close of 4.90 HKD. The stock has fluctuated within a day range of 4.90 HKD to 4.90 HKD, while its 52-week range spans from 3.40 HKD to 7.80 HKD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.